NDC properties for "terbutaline sulfate 5 MG Oral Tablet" (RxCUI 857683)
About this data
The tables show NDC propoerties for terbutaline sulfate 5 MG Oral Tablet with the RxCUI 857683
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for terbutaline sulfate 5 MG Oral Tablet (RxCUI 857683)
| ANDA | ANDA075877 |
|---|---|
| ANDA | ANDA077152 |
| ANDA | ANDA211832 |
| MMSL_CODE | BD3288 |
| MMSL_CODE | CD3288 |
| RxCUI | 857683 |
| SNOMEDCT | 320203000 |
| SPL_SET_ID | 0a95bc4f-34d3-4b5e-841b-6839e1c1e0c7 |
| SPL_SET_ID | 382dcebb-6e41-4335-818d-b5822e3fb884 |
| SPL_SET_ID | 3a4e5046-293c-4616-8679-6da65f31626b |
| SPL_SET_ID | 859267c6-3d14-4123-9b9d-4fc248f09726 |
| SPL_SET_ID | 879be756-991a-42c5-a381-9c8c2ad1fbdb |
| SPL_SET_ID | 94742710-e87e-4e1c-85ee-0a2e7a77f0de |
| SPL_SET_ID | d810a15b-3e10-4f6c-a36e-8ddecbaba9c3 |
| SPL_SET_ID | fbf54709-5857-4dbc-9233-ebd7abff88c8 |
| VUID | 4004615 |
| Prescribable Synonym | terbutaline sulfate 5 MG Oral Tablet |
| RXNAV_STR | terbutaline sulfate 5 MG Oral Tablet |
| RxNorm Name | terbutaline sulfate 5 MG Oral Tablet |
| Related queries | Interactions (for RxCUI 857683) |
NDC Properties
NDC Item 00115262201
| NDC 9 | 0115-2622 |
|---|---|
| NDC 10 | 0115-2622-01 |
| NDC Item | 00115262201 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2622-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2622 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0115-2622 |
NDC Item 00527131101
| NDC 9 | 0527-1311 |
|---|---|
| NDC 10 | 0527-1311-01 |
| NDC Item | 00527131101 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1311-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1311 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0527-1311 |
NDC Item 10135058001
| NDC 9 | 10135-580 |
|---|---|
| NDC 10 | 10135-580-01 |
| NDC Item | 10135058001 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-580-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1311 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 10135-580 |
NDC Item 24979013301
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-01 |
| NDC Item | 24979013301 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-133-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 24979013303
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-03 |
| NDC Item | 24979013303 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-133-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 43063055804
| NDC 9 | 43063-558 |
|---|---|
| NDC 10 | 43063-558-04 |
| NDC Item | 43063055804 |
| Packaging | 4 TABLET in 1 BOTTLE, PLASTIC (43063-558-04) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 359029 |
| Imprint code | LCI;1311 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2005-03-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 43063-558 |
NDC Item 62135052590
| NDC 9 | 62135-525 |
|---|---|
| NDC 10 | 62135-525-90 |
| NDC Item | 62135052590 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-525-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1311 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62135-525 |
NDC Item 62559072201
| NDC 9 | 62559-722 |
|---|---|
| NDC 10 | 62559-722-01 |
| NDC Item | 62559072201 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-722-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;722 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62559-722 |
NDC Item 71205093900
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-00 |
| NDC Item | 71205093900 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-939-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093930
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-30 |
| NDC Item | 71205093930 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-939-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093955
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-55 |
| NDC Item | 71205093955 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-939-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093960
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-60 |
| NDC Item | 71205093960 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-939-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093990
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-90 |
| NDC Item | 71205093990 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-939-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 00115262201
| NDC 9 | 0115-2622 |
|---|---|
| NDC 10 | 0115-2622-01 |
| NDC Item | 00115262201 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2622-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2622 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0115-2622 |
NDC Item 00527131101
| NDC 9 | 0527-1311 |
|---|---|
| NDC 10 | 0527-1311-01 |
| NDC Item | 00527131101 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1311-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1311 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0527-1311 |
NDC Item 10135058001
| NDC 9 | 10135-580 |
|---|---|
| NDC 10 | 10135-580-01 |
| NDC Item | 10135058001 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-580-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1311 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 10135-580 |
NDC Item 24979013301
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-01 |
| NDC Item | 24979013301 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-133-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 24979013303
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-03 |
| NDC Item | 24979013303 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-133-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 43063055804
| NDC 9 | 43063-558 |
|---|---|
| NDC 10 | 43063-558-04 |
| NDC Item | 43063055804 |
| Packaging | 4 TABLET in 1 BOTTLE, PLASTIC (43063-558-04) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 359029 |
| Imprint code | LCI;1311 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2005-03-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 43063-558 |
NDC Item 62135052590
| NDC 9 | 62135-525 |
|---|---|
| NDC 10 | 62135-525-90 |
| NDC Item | 62135052590 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-525-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1311 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62135-525 |
NDC Item 62559072201
| NDC 9 | 62559-722 |
|---|---|
| NDC 10 | 62559-722-01 |
| NDC Item | 62559072201 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-722-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;722 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62559-722 |
NDC Item 71205093900
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-00 |
| NDC Item | 71205093900 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-939-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093930
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-30 |
| NDC Item | 71205093930 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-939-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093955
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-55 |
| NDC Item | 71205093955 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-939-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093960
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-60 |
| NDC Item | 71205093960 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-939-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093990
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-90 |
| NDC Item | 71205093990 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-939-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 00115262201
| NDC 9 | 0115-2622 |
|---|---|
| NDC 10 | 0115-2622-01 |
| NDC Item | 00115262201 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2622-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2622 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0115-2622 |
NDC Item 00527131101
| NDC 9 | 0527-1311 |
|---|---|
| NDC 10 | 0527-1311-01 |
| NDC Item | 00527131101 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1311-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1311 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0527-1311 |
NDC Item 10135058001
| NDC 9 | 10135-580 |
|---|---|
| NDC 10 | 10135-580-01 |
| NDC Item | 10135058001 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-580-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1311 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 10135-580 |
NDC Item 24979013301
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-01 |
| NDC Item | 24979013301 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-133-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 24979013303
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-03 |
| NDC Item | 24979013303 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-133-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 43063055804
| NDC 9 | 43063-558 |
|---|---|
| NDC 10 | 43063-558-04 |
| NDC Item | 43063055804 |
| Packaging | 4 TABLET in 1 BOTTLE, PLASTIC (43063-558-04) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 359029 |
| Imprint code | LCI;1311 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2005-03-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 43063-558 |
NDC Item 62135052590
| NDC 9 | 62135-525 |
|---|---|
| NDC 10 | 62135-525-90 |
| NDC Item | 62135052590 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-525-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1311 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62135-525 |
NDC Item 62559072201
| NDC 9 | 62559-722 |
|---|---|
| NDC 10 | 62559-722-01 |
| NDC Item | 62559072201 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-722-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;722 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62559-722 |
NDC Item 71205093900
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-00 |
| NDC Item | 71205093900 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-939-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093930
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-30 |
| NDC Item | 71205093930 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-939-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093955
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-55 |
| NDC Item | 71205093955 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-939-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093960
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-60 |
| NDC Item | 71205093960 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-939-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093990
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-90 |
| NDC Item | 71205093990 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-939-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 00115262201
| NDC 9 | 0115-2622 |
|---|---|
| NDC 10 | 0115-2622-01 |
| NDC Item | 00115262201 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2622-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2622 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0115-2622 |
NDC Item 00527131101
| NDC 9 | 0527-1311 |
|---|---|
| NDC 10 | 0527-1311-01 |
| NDC Item | 00527131101 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1311-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1311 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0527-1311 |
NDC Item 10135058001
| NDC 9 | 10135-580 |
|---|---|
| NDC 10 | 10135-580-01 |
| NDC Item | 10135058001 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-580-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1311 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 10135-580 |
NDC Item 24979013301
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-01 |
| NDC Item | 24979013301 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-133-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 24979013303
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-03 |
| NDC Item | 24979013303 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-133-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 43063055804
| NDC 9 | 43063-558 |
|---|---|
| NDC 10 | 43063-558-04 |
| NDC Item | 43063055804 |
| Packaging | 4 TABLET in 1 BOTTLE, PLASTIC (43063-558-04) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 359029 |
| Imprint code | LCI;1311 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2005-03-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 43063-558 |
NDC Item 62135052590
| NDC 9 | 62135-525 |
|---|---|
| NDC 10 | 62135-525-90 |
| NDC Item | 62135052590 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-525-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1311 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62135-525 |
NDC Item 62559072201
| NDC 9 | 62559-722 |
|---|---|
| NDC 10 | 62559-722-01 |
| NDC Item | 62559072201 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-722-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;722 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62559-722 |
NDC Item 71205093900
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-00 |
| NDC Item | 71205093900 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-939-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093930
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-30 |
| NDC Item | 71205093930 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-939-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093955
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-55 |
| NDC Item | 71205093955 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-939-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093960
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-60 |
| NDC Item | 71205093960 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-939-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093990
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-90 |
| NDC Item | 71205093990 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-939-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 00115262201
| NDC 9 | 0115-2622 |
|---|---|
| NDC 10 | 0115-2622-01 |
| NDC Item | 00115262201 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2622-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2622 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0115-2622 |
NDC Item 00527131101
| NDC 9 | 0527-1311 |
|---|---|
| NDC 10 | 0527-1311-01 |
| NDC Item | 00527131101 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1311-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1311 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0527-1311 |
NDC Item 10135058001
| NDC 9 | 10135-580 |
|---|---|
| NDC 10 | 10135-580-01 |
| NDC Item | 10135058001 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-580-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1311 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 10135-580 |
NDC Item 24979013301
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-01 |
| NDC Item | 24979013301 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-133-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 24979013303
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-03 |
| NDC Item | 24979013303 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-133-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 43063055804
| NDC 9 | 43063-558 |
|---|---|
| NDC 10 | 43063-558-04 |
| NDC Item | 43063055804 |
| Packaging | 4 TABLET in 1 BOTTLE, PLASTIC (43063-558-04) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 359029 |
| Imprint code | LCI;1311 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2005-03-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 43063-558 |
NDC Item 62135052590
| NDC 9 | 62135-525 |
|---|---|
| NDC 10 | 62135-525-90 |
| NDC Item | 62135052590 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-525-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1311 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62135-525 |
NDC Item 62559072201
| NDC 9 | 62559-722 |
|---|---|
| NDC 10 | 62559-722-01 |
| NDC Item | 62559072201 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-722-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;722 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62559-722 |
NDC Item 71205093900
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-00 |
| NDC Item | 71205093900 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-939-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093930
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-30 |
| NDC Item | 71205093930 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-939-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093955
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-55 |
| NDC Item | 71205093955 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-939-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093960
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-60 |
| NDC Item | 71205093960 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-939-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093990
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-90 |
| NDC Item | 71205093990 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-939-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 00115262201
| NDC 9 | 0115-2622 |
|---|---|
| NDC 10 | 0115-2622-01 |
| NDC Item | 00115262201 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2622-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2622 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0115-2622 |
NDC Item 00527131101
| NDC 9 | 0527-1311 |
|---|---|
| NDC 10 | 0527-1311-01 |
| NDC Item | 00527131101 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1311-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1311 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0527-1311 |
NDC Item 10135058001
| NDC 9 | 10135-580 |
|---|---|
| NDC 10 | 10135-580-01 |
| NDC Item | 10135058001 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-580-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1311 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 10135-580 |
NDC Item 24979013301
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-01 |
| NDC Item | 24979013301 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-133-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 24979013303
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-03 |
| NDC Item | 24979013303 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-133-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 43063055804
| NDC 9 | 43063-558 |
|---|---|
| NDC 10 | 43063-558-04 |
| NDC Item | 43063055804 |
| Packaging | 4 TABLET in 1 BOTTLE, PLASTIC (43063-558-04) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 359029 |
| Imprint code | LCI;1311 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2005-03-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 43063-558 |
NDC Item 62135052590
| NDC 9 | 62135-525 |
|---|---|
| NDC 10 | 62135-525-90 |
| NDC Item | 62135052590 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-525-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1311 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62135-525 |
NDC Item 62559072201
| NDC 9 | 62559-722 |
|---|---|
| NDC 10 | 62559-722-01 |
| NDC Item | 62559072201 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-722-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;722 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62559-722 |
NDC Item 71205093900
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-00 |
| NDC Item | 71205093900 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-939-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093930
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-30 |
| NDC Item | 71205093930 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-939-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093955
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-55 |
| NDC Item | 71205093955 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-939-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093960
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-60 |
| NDC Item | 71205093960 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-939-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093990
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-90 |
| NDC Item | 71205093990 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-939-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 00115262201
| NDC 9 | 0115-2622 |
|---|---|
| NDC 10 | 0115-2622-01 |
| NDC Item | 00115262201 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2622-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2622 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0115-2622 |
NDC Item 00527131101
| NDC 9 | 0527-1311 |
|---|---|
| NDC 10 | 0527-1311-01 |
| NDC Item | 00527131101 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1311-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1311 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0527-1311 |
NDC Item 10135058001
| NDC 9 | 10135-580 |
|---|---|
| NDC 10 | 10135-580-01 |
| NDC Item | 10135058001 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-580-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1311 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 10135-580 |
NDC Item 24979013301
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-01 |
| NDC Item | 24979013301 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-133-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 24979013303
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-03 |
| NDC Item | 24979013303 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-133-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 43063055804
| NDC 9 | 43063-558 |
|---|---|
| NDC 10 | 43063-558-04 |
| NDC Item | 43063055804 |
| Packaging | 4 TABLET in 1 BOTTLE, PLASTIC (43063-558-04) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 359029 |
| Imprint code | LCI;1311 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2005-03-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 43063-558 |
NDC Item 62135052590
| NDC 9 | 62135-525 |
|---|---|
| NDC 10 | 62135-525-90 |
| NDC Item | 62135052590 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-525-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1311 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62135-525 |
NDC Item 62559072201
| NDC 9 | 62559-722 |
|---|---|
| NDC 10 | 62559-722-01 |
| NDC Item | 62559072201 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-722-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;722 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62559-722 |
NDC Item 71205093900
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-00 |
| NDC Item | 71205093900 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-939-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093930
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-30 |
| NDC Item | 71205093930 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-939-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093955
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-55 |
| NDC Item | 71205093955 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-939-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093960
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-60 |
| NDC Item | 71205093960 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-939-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093990
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-90 |
| NDC Item | 71205093990 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-939-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 00115262201
| NDC 9 | 0115-2622 |
|---|---|
| NDC 10 | 0115-2622-01 |
| NDC Item | 00115262201 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2622-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2622 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0115-2622 |
NDC Item 00527131101
| NDC 9 | 0527-1311 |
|---|---|
| NDC 10 | 0527-1311-01 |
| NDC Item | 00527131101 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1311-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1311 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0527-1311 |
NDC Item 10135058001
| NDC 9 | 10135-580 |
|---|---|
| NDC 10 | 10135-580-01 |
| NDC Item | 10135058001 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-580-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1311 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 10135-580 |
NDC Item 24979013301
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-01 |
| NDC Item | 24979013301 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-133-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 24979013303
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-03 |
| NDC Item | 24979013303 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-133-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 43063055804
| NDC 9 | 43063-558 |
|---|---|
| NDC 10 | 43063-558-04 |
| NDC Item | 43063055804 |
| Packaging | 4 TABLET in 1 BOTTLE, PLASTIC (43063-558-04) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 359029 |
| Imprint code | LCI;1311 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2005-03-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 43063-558 |
NDC Item 62135052590
| NDC 9 | 62135-525 |
|---|---|
| NDC 10 | 62135-525-90 |
| NDC Item | 62135052590 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-525-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1311 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62135-525 |
NDC Item 62559072201
| NDC 9 | 62559-722 |
|---|---|
| NDC 10 | 62559-722-01 |
| NDC Item | 62559072201 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-722-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;722 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62559-722 |
NDC Item 71205093900
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-00 |
| NDC Item | 71205093900 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-939-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093930
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-30 |
| NDC Item | 71205093930 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-939-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093955
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-55 |
| NDC Item | 71205093955 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-939-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093960
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-60 |
| NDC Item | 71205093960 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-939-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093990
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-90 |
| NDC Item | 71205093990 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-939-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 00115262201
| NDC 9 | 0115-2622 |
|---|---|
| NDC 10 | 0115-2622-01 |
| NDC Item | 00115262201 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2622-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2622 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0115-2622 |
NDC Item 00527131101
| NDC 9 | 0527-1311 |
|---|---|
| NDC 10 | 0527-1311-01 |
| NDC Item | 00527131101 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1311-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1311 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0527-1311 |
NDC Item 10135058001
| NDC 9 | 10135-580 |
|---|---|
| NDC 10 | 10135-580-01 |
| NDC Item | 10135058001 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-580-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1311 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 10135-580 |
NDC Item 24979013301
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-01 |
| NDC Item | 24979013301 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-133-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 24979013303
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-03 |
| NDC Item | 24979013303 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-133-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 43063055804
| NDC 9 | 43063-558 |
|---|---|
| NDC 10 | 43063-558-04 |
| NDC Item | 43063055804 |
| Packaging | 4 TABLET in 1 BOTTLE, PLASTIC (43063-558-04) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 359029 |
| Imprint code | LCI;1311 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2005-03-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 43063-558 |
NDC Item 62135052590
| NDC 9 | 62135-525 |
|---|---|
| NDC 10 | 62135-525-90 |
| NDC Item | 62135052590 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-525-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1311 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62135-525 |
NDC Item 62559072201
| NDC 9 | 62559-722 |
|---|---|
| NDC 10 | 62559-722-01 |
| NDC Item | 62559072201 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-722-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;722 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62559-722 |
NDC Item 71205093900
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-00 |
| NDC Item | 71205093900 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-939-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093930
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-30 |
| NDC Item | 71205093930 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-939-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093955
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-55 |
| NDC Item | 71205093955 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-939-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093960
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-60 |
| NDC Item | 71205093960 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-939-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093990
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-90 |
| NDC Item | 71205093990 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-939-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 00115262201
| NDC 9 | 0115-2622 |
|---|---|
| NDC 10 | 0115-2622-01 |
| NDC Item | 00115262201 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2622-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2622 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0115-2622 |
NDC Item 00527131101
| NDC 9 | 0527-1311 |
|---|---|
| NDC 10 | 0527-1311-01 |
| NDC Item | 00527131101 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1311-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1311 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0527-1311 |
NDC Item 10135058001
| NDC 9 | 10135-580 |
|---|---|
| NDC 10 | 10135-580-01 |
| NDC Item | 10135058001 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-580-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1311 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 10135-580 |
NDC Item 24979013301
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-01 |
| NDC Item | 24979013301 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-133-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 24979013303
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-03 |
| NDC Item | 24979013303 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-133-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 43063055804
| NDC 9 | 43063-558 |
|---|---|
| NDC 10 | 43063-558-04 |
| NDC Item | 43063055804 |
| Packaging | 4 TABLET in 1 BOTTLE, PLASTIC (43063-558-04) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 359029 |
| Imprint code | LCI;1311 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2005-03-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 43063-558 |
NDC Item 62135052590
| NDC 9 | 62135-525 |
|---|---|
| NDC 10 | 62135-525-90 |
| NDC Item | 62135052590 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-525-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1311 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62135-525 |
NDC Item 62559072201
| NDC 9 | 62559-722 |
|---|---|
| NDC 10 | 62559-722-01 |
| NDC Item | 62559072201 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-722-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;722 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62559-722 |
NDC Item 71205093900
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-00 |
| NDC Item | 71205093900 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-939-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093930
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-30 |
| NDC Item | 71205093930 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-939-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093955
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-55 |
| NDC Item | 71205093955 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-939-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093960
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-60 |
| NDC Item | 71205093960 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-939-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093990
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-90 |
| NDC Item | 71205093990 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-939-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 00115262201
| NDC 9 | 0115-2622 |
|---|---|
| NDC 10 | 0115-2622-01 |
| NDC Item | 00115262201 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2622-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2622 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0115-2622 |
NDC Item 00527131101
| NDC 9 | 0527-1311 |
|---|---|
| NDC 10 | 0527-1311-01 |
| NDC Item | 00527131101 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1311-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1311 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0527-1311 |
NDC Item 10135058001
| NDC 9 | 10135-580 |
|---|---|
| NDC 10 | 10135-580-01 |
| NDC Item | 10135058001 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-580-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1311 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 10135-580 |
NDC Item 24979013301
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-01 |
| NDC Item | 24979013301 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-133-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 24979013303
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-03 |
| NDC Item | 24979013303 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-133-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 43063055804
| NDC 9 | 43063-558 |
|---|---|
| NDC 10 | 43063-558-04 |
| NDC Item | 43063055804 |
| Packaging | 4 TABLET in 1 BOTTLE, PLASTIC (43063-558-04) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 359029 |
| Imprint code | LCI;1311 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2005-03-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 43063-558 |
NDC Item 62135052590
| NDC 9 | 62135-525 |
|---|---|
| NDC 10 | 62135-525-90 |
| NDC Item | 62135052590 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-525-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1311 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62135-525 |
NDC Item 62559072201
| NDC 9 | 62559-722 |
|---|---|
| NDC 10 | 62559-722-01 |
| NDC Item | 62559072201 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-722-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;722 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62559-722 |
NDC Item 71205093900
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-00 |
| NDC Item | 71205093900 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-939-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093930
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-30 |
| NDC Item | 71205093930 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-939-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093955
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-55 |
| NDC Item | 71205093955 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-939-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093960
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-60 |
| NDC Item | 71205093960 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-939-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093990
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-90 |
| NDC Item | 71205093990 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-939-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 00115262201
| NDC 9 | 0115-2622 |
|---|---|
| NDC 10 | 0115-2622-01 |
| NDC Item | 00115262201 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2622-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2622 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0115-2622 |
NDC Item 00527131101
| NDC 9 | 0527-1311 |
|---|---|
| NDC 10 | 0527-1311-01 |
| NDC Item | 00527131101 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1311-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1311 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0527-1311 |
NDC Item 10135058001
| NDC 9 | 10135-580 |
|---|---|
| NDC 10 | 10135-580-01 |
| NDC Item | 10135058001 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-580-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1311 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 10135-580 |
NDC Item 24979013301
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-01 |
| NDC Item | 24979013301 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-133-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 24979013303
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-03 |
| NDC Item | 24979013303 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-133-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 43063055804
| NDC 9 | 43063-558 |
|---|---|
| NDC 10 | 43063-558-04 |
| NDC Item | 43063055804 |
| Packaging | 4 TABLET in 1 BOTTLE, PLASTIC (43063-558-04) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 359029 |
| Imprint code | LCI;1311 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2005-03-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 43063-558 |
NDC Item 62135052590
| NDC 9 | 62135-525 |
|---|---|
| NDC 10 | 62135-525-90 |
| NDC Item | 62135052590 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-525-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1311 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62135-525 |
NDC Item 62559072201
| NDC 9 | 62559-722 |
|---|---|
| NDC 10 | 62559-722-01 |
| NDC Item | 62559072201 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-722-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;722 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62559-722 |
NDC Item 71205093900
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-00 |
| NDC Item | 71205093900 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-939-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093930
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-30 |
| NDC Item | 71205093930 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-939-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093955
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-55 |
| NDC Item | 71205093955 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-939-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093960
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-60 |
| NDC Item | 71205093960 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-939-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093990
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-90 |
| NDC Item | 71205093990 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-939-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 00115262201
| NDC 9 | 0115-2622 |
|---|---|
| NDC 10 | 0115-2622-01 |
| NDC Item | 00115262201 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2622-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2622 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0115-2622 |
NDC Item 00527131101
| NDC 9 | 0527-1311 |
|---|---|
| NDC 10 | 0527-1311-01 |
| NDC Item | 00527131101 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1311-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1311 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 0527-1311 |
NDC Item 10135058001
| NDC 9 | 10135-580 |
|---|---|
| NDC 10 | 10135-580-01 |
| NDC Item | 10135058001 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-580-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1311 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 10135-580 |
NDC Item 24979013301
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-01 |
| NDC Item | 24979013301 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-133-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 24979013303
| NDC 9 | 24979-133 |
|---|---|
| NDC 10 | 24979-133-03 |
| NDC Item | 24979013303 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-133-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T;133 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 24979-133 |
NDC Item 43063055804
| NDC 9 | 43063-558 |
|---|---|
| NDC 10 | 43063-558-04 |
| NDC Item | 43063055804 |
| Packaging | 4 TABLET in 1 BOTTLE, PLASTIC (43063-558-04) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 359029 |
| Imprint code | LCI;1311 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-09-23 |
| Marketing effective time low | 2005-03-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 43063-558 |
NDC Item 62135052590
| NDC 9 | 62135-525 |
|---|---|
| NDC 10 | 62135-525-90 |
| NDC Item | 62135052590 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-525-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1311 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62135-525 |
NDC Item 62559072201
| NDC 9 | 62559-722 |
|---|---|
| NDC 10 | 62559-722-01 |
| NDC Item | 62559072201 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-722-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;722 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 62559-722 |
NDC Item 71205093900
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-00 |
| NDC Item | 71205093900 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-939-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093930
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-30 |
| NDC Item | 71205093930 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-939-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093955
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-55 |
| NDC Item | 71205093955 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-939-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093960
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-60 |
| NDC Item | 71205093960 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-939-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |
NDC Item 71205093990
| NDC 9 | 71205-939 |
|---|---|
| NDC 10 | 71205-939-90 |
| NDC Item | 71205093990 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-939-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T;133 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 8 mm |
| Related queries | Properties for NDC 9 71205-939 |